Literature DB >> 3546375

Demonstration of defective C3-receptor-mediated clearance by the reticuloendothelial system in patients with acquired immunodeficiency syndrome.

B S Bender, J F Bohnsack, S H Sourlis, M M Frank, T C Quinn.   

Abstract

The function of macrophage C3 receptors was assessed in vivo by measuring the clearance of C3-sensitized autologous erythrocytes in seven acquired immunodeficiency syndrome (AIDS) patients, eight healthy homosexual men, eight healthy heterosexual men, and four infected controls. Healthy heterosexual men had an initial clearance of 50.1 +/- 2.0% of the inoculum, with a release of a small portion of these cells (10.9 +/- 1.3%) into the circulation. Healthy homosexual men had a greater initial clearance of 66.0 +/- 4.2% (P less than 0.01) followed by a similar release (14.0 +/- 3.3%). AIDS patients had an initial clearance of 60.6 +/- 7.5% but had a relatively large release of cells (25.6 +/- 3.2%) (P less than 0.005 vs. heterosexuals; P less than 0.05 vs. homosexuals), suggesting a failure of macrophage phagocytosis. Infected controls had an initial clearance of 59.4 +/- 4.9%, with a release of 19.6 +/- 3.8% (P = NS vs. AIDS). These data, in addition to Fc-receptor dysfunction, demonstrate a global reticuloendothelial system dysfunction in AIDS patients. This may contribute to their frequent infections with opportunistic pathogens and inappropriate immune responses against these microorganisms.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3546375      PMCID: PMC424182          DOI: 10.1172/JCI112876

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Phagocytic and fungicidal activity of monocytes from patients with acquired immunodeficiency syndrome.

Authors:  R G Washburn; C U Tuazon; J E Bennett
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

2.  Retrovirus resembling HTLV in macrophages of patients with AIDS.

Authors:  F Gyorkey; J L Melnick; J G Sinkovics; P Gyorkey
Journal:  Lancet       Date:  1985-01-12       Impact factor: 79.321

Review 3.  AIDS--an immunologic reevaluation.

Authors:  M Seligmann; L Chess; J L Fahey; A S Fauci; P J Lachmann; J L'Age-Stehr; J Ngu; A J Pinching; F S Rosen; T J Spira
Journal:  N Engl J Med       Date:  1984-11-15       Impact factor: 91.245

4.  Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus.

Authors:  M A Gonda; F Wong-Staal; R C Gallo; J E Clements; O Narayan; R V Gilden
Journal:  Science       Date:  1985-01-11       Impact factor: 47.728

5.  Hematologic abnormalities in the acquired immune deficiency syndrome.

Authors:  J L Spivak; B S Bender; T C Quinn
Journal:  Am J Med       Date:  1984-08       Impact factor: 4.965

6.  Immunologic abnormalities in the acquired immunodeficiency syndrome (AIDS).

Authors:  A S Fauci
Journal:  Clin Res       Date:  1984-12

7.  The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.

Authors:  A G Dalgleish; P C Beverley; P R Clapham; D H Crawford; M F Greaves; R A Weiss
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

8.  Defective monocyte function in acquired immune deficiency syndrome (AIDS): evidence from a monocyte-dependent T-cell proliferative system.

Authors:  H E Prince; D J Moody; B I Shubin; J L Fahey
Journal:  J Clin Immunol       Date:  1985-01       Impact factor: 8.317

9.  Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis.

Authors:  P D Smith; K Ohura; H Masur; H C Lane; A S Fauci; S M Wahl
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

10.  Serum immunoglobulin elevations in the acquired immunodeficiency syndrome (AIDS): IgG, IgA, IgM, and IgD.

Authors:  Q Chess; J Daniels; E North; N T Macris
Journal:  Diagn Immunol       Date:  1984
View more
  9 in total

1.  Modulation of the effector function of human macrophages for Histoplasma capsulatum by HIV-1. Role of the envelope glycoprotein gp120.

Authors:  S Chaturvedi; S L Newman
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

Review 2.  The potential role of granulocyte-macrophage colony stimulating factor in therapy of fungal infections: a commentary.

Authors:  G P Bodey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-05       Impact factor: 3.267

Review 3.  In vivo clearance by the mononuclear phagocyte system in humans: an overview of methods and their interpretation.

Authors:  C Halma; M R Daha; L A van Es
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

4.  Effect of hepatitis C virus coinfection on humoral immune alterations in naïve HIV-infected adults on HAART: a three year follow-up study.

Authors:  Natalia Soriano-Sarabia; Manuel Leal; Carmen Delgado; Sonia Molina-Pinelo; Beatriz De Felipe; Ezequiel Ruiz-Mateos; Armando Sánchez-Quijano; Eduardo Lissen; Alejandro Vallejo
Journal:  J Clin Immunol       Date:  2005-05       Impact factor: 8.317

5.  Rapid clearance of simian immunodeficiency virus particles from plasma of rhesus macaques.

Authors:  L Zhang; P J Dailey; T He; A Gettie; S Bonhoeffer; A S Perelson; D D Ho
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

Review 6.  The use of GM-CSF in AIDS.

Authors:  D T Scadden
Journal:  Infection       Date:  1992       Impact factor: 3.553

7.  Increased expression of IgG Fc receptor type I on neutrophils and monocytes from HIV-infected subjects.

Authors:  F Capsoni; F Minonzio; A M Ongari; G Colombo; G P Rizzardi; P Bonara; A D'Arminio-Monforte; C Zanussi
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

8.  HIV-1 infection of monocyte-derived macrophages reduces Fc and complement receptor expression.

Authors:  S J Kent; G Stent; S Sonza; S D Hunter; S M Crowe
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

9.  HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy.

Authors:  L Morris; J M Binley; B A Clas; S Bonhoeffer; T P Astill; R Kost; A Hurley; Y Cao; M Markowitz; D D Ho; J P Moore
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.